The mechanisms of HCM occurrence caused by point mutations remain poorly understood, in contrast to the truncated forms of cMyBP-C, which lead to a decrease in the amount of protein in the sarcomere, acceleration of cross-bridge cycling, an increase in force, and as a consequence, myocardial hypertrophy [16]. This evidence concerns the gene MYBPC3 and cardiac hypertrophy.